Eyebrow alopecia associated with cladribine treatment for multiple sclerosis

Neurol Sci. 2023 Oct;44(10):3735-3736. doi: 10.1007/s10072-023-06874-x. Epub 2023 May 30.

Authors

Maja Stefanovic Budimkic¹, Jovana Ivanovic², Nikola Momcilovic², Sarlota Mesaros¹, Jelena Drulovic³

Affiliations

¹ Neurology Clinic, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
² Neurology Clinic, University Clinical Center of Serbia, Belgrade, Serbia.
³ Neurology Clinic, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia. drulovicjelena@gmail.com.

PMID: 37249666
DOI: 10.1007/s10072-023-06874-x

No abstract available

Publication types

Letter

MeSH terms

Alopecia / chemically induced
Alopecia / drug therapy
Cladribine / adverse effects
Eyebrows
Humans
Immunosuppressive Agents / adverse effects
Multiple Sclerosis* / drug therapy
Multiple Sclerosis, Relapsing-Remitting* / drug therapy

Substances

Cladribine
Immunosuppressive Agents